Hizentra is an Ig* therapy that provides proven protection for PI and CIDP with the convenience of self-administration, so you can focus on everyday living


What's the difference between Hizentra and intravenous Ig (IVIg)?

Hizentra is a subcutaneous infusion therapy, which means IV access is not involved.
Instead, you can self-administer by infusing just under the skin, not into your veins, after receiving training from your doctor.

Hizentra gives you proven protection with convenient dosing to best fit your lifestyle and preference.

Hizentra is a prescription medicine used to treat primary immune deficiency (Pl) in patients 2 years and older and as maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.

Support programs to help you get started

CSL Behring Premier Start logo

With Premier Start, you can receive:

  • A free 1-month supply of Hizentra and infusion equipment
  • Free at-home visits by a trained nurse
Discover how to start
Hizentra Co-Pay Relief

The Hizentra Co-Pay Relief program helps eligible people afford their therapy by assisting with monthly out-of-pocket expenses for Hizentra (up to $5,000 for each year, with no monthly cap). Most patients with commercial insurance pay $0 out-of-pocket.

See if you are eligible
CSL Behring Assurance logo

CSL Behring Assurance is a program that can help eligible patients continue to receive treatment even if they experience a lapse in third-party private health insurance.

Learn how it works
Welcome Kit

Sign up for a free Welcome Kit

This kit provides important resources to help you start and stay on Hizentra.

View information about Hizentra for:


primary immunodeficiency


chronic inflammatory demyelinating polyneuropathy

You are now leaving the current website.

Do you want to continue?

No Yes